News from WCM

A team led by researchers at Weill Cornell Medicine and the Howard Hughes Medical Institute (HHMI) Janelia Research Campus has developed and tested a high-resolution sensor for tracking the real-time dynamics of ATP levels in cells and within subcellular compartments. 

Weill Cornell Graduate School of Medical Sciences highlighted students in the Class of 2024 for their academic achievements during its convocation ceremony on May 15.

Students from the Weill Cornell Medical College Class of 2024 were recognized for their dedication to scholarship, excellence in research, devotion to teaching and service and exceptional professional qualities on May 15 during Convocation.

Weill Cornell Medicine-Qatar (WCM-Q) awarded Cornell University medical degrees to 50 new doctors—the largest graduating cohort to date—at the institution’s annual graduation ceremony on May 9.

A team led by Dr. Eddie Imada, assistant professor of research in pathology and laboratory medicine, has been awarded a three-year, $1.5 million United States Department of Defense grant for research on a cellular process called alternative polyadenylation and its role in prostate cancer.

A team co-led by researchers at Weill Cornell Medicine and the New York Genome Center has developed an advanced method for revealing how gene mutations disrupt the normal packaging of DNA. 

Inulin, a type of fiber found in certain plant-based foods and fiber supplements, causes inflammation in the gut and exacerbates inflammatory bowel disease in a preclinical model, according to a new study by Weill Cornell Medicine investigators.

Early-onset heart failure is alarmingly common in urban Haiti—over 15-fold higher than previously estimated—according to a study conducted by Weill Cornell Medicine researchers in partnership with the Haitian medical organization GHESKIO.

Microbes in the mammalian gut can significantly change their hosts’ amino acid and glucose metabolism, acting almost like an extra liver, according to a new preclinical study by Weill Cornell Medicine investigators.

Dr. Adam D. Cheriff, a physician and healthcare executive with more than 20 years of leadership experience, has been named the new chief operating officer of Weill Cornell Medicine's Physician Organization, effective May 1. 

Dr. Carl Nathan, chair of the department of microbiology and immunology and the R.A. Rees Pritchett Professor of Microbiology at Weill Cornell Medicine, answers questions about interferon-γ's history and future.

Dr. C. Noel Bairey Merz delivered a keynote address entitled “Sex and Gender Medicine: Science, Policy and Health Disparities in CVD,” as part of Weill Cornell Medicine's sixth annual Diversity Week.

Weill Cornell Medicine’s Celebration of Diversity, part of the institution’s sixth annual Diversity Week, was held on April 15. The awardees were honored for their commitment to diversity and inclusivity in academic medicine through exemplary contributions in mentorship, research, clinical care, community service and advocacy.

To imagine a society without racial disparities in health care, we must consider the real reasons inequities exist, said Dr. Thomas LaVeist in his keynote address on April 15 for Weill Cornell Medicine’s sixth annual Diversity Week.

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.

Launched in 2019, the IMSD Program aims to boost admissions and retention rates of doctoral students primarily from self-identified historically underrepresented groups in science. 

Researchers at Weill Cornell Medicine have developed a powerful, new technique to generate “movies” of changing protein structures at speeds of up to 50 frames per second.

Treatment for rheumatoid arthritis (RA) has come a long way in recent years. In many cases, a battery of...

Investigators at Weill Cornell Medicine have assembled the most comprehensive atlas to date of messenger RNA (mRNA) variants in the mouse and human brain, which will be important in understanding brain development, neuron specialization and other brain functions.

A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms.